BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 20407930)

  • 1. Role of surgery combined with kinase inhibition in the management of gastrointestinal stromal tumor (GIST).
    Hohenberger P; Eisenberg B
    Ann Surg Oncol; 2010 Oct; 17(10):2585-600. PubMed ID: 20407930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression.
    Liegl B; Hornick JL; Antonescu CR; Corless CL; Fletcher CD
    Am J Surg Pathol; 2009 Feb; 33(2):218-26. PubMed ID: 18830121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.
    Andtbacka RH; Ng CS; Scaife CL; Cormier JN; Hunt KK; Pisters PW; Pollock RE; Benjamin RS; Burgess MA; Chen LL; Trent J; Patel SR; Raymond K; Feig BW
    Ann Surg Oncol; 2007 Jan; 14(1):14-24. PubMed ID: 17072676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal stromal tumor: 5 years later.
    van der Zwan SM; DeMatteo RP
    Cancer; 2005 Nov; 104(9):1781-8. PubMed ID: 16136600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
    Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
    Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
    Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant and neoadjuvant therapy for primary GIST.
    Eisenberg BL; Smith KD
    Cancer Chemother Pharmacol; 2011 Jan; 67 Suppl 1():S3-8. PubMed ID: 21116626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal stromal tumors and the evolution of targeted therapy.
    Sanborn RE; Blanke CD
    Clin Adv Hematol Oncol; 2005 Aug; 3(8):647-57. PubMed ID: 16167051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current aspects of treatment in gastrointestinal stromal tumors (GIST)].
    Láng I; Hitre E
    Orv Hetil; 2005 May; 146(18 Suppl 1):935-41. PubMed ID: 15921308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of gastrointestinal stromal tumors in the imatinib era: selected case studies.
    Benjamin RS; Blanke CD; Blay JY; Bonvalot S; Eisenberg B
    Oncologist; 2006 Jan; 11(1):9-20. PubMed ID: 16401709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [GIST: our experience].
    Rossi MT; Fasano G; Morlino A; Scutari F
    G Chir; 2009; 30(1-2):41-5. PubMed ID: 19272232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should surgical resection be combined with imatinib therapy for locally advanced or metastatic gastrointestinal stromal tumors?
    Yoon SS; Tanabe KK
    Ann Surg Oncol; 2007 Jun; 14(6):1784-6. PubMed ID: 17356951
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era.
    Bonvalot S; Eldweny H; Péchoux CL; Vanel D; Terrier P; Cavalcanti A; Robert C; Lassau N; Cesne AL
    Ann Surg Oncol; 2006 Dec; 13(12):1596-603. PubMed ID: 16957966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonadherence to imatinib treatment in patients with gastrointestinal stromal tumors: the ADAGIO study.
    Mazzeo F; Duck L; Joosens E; Dirix L; Focan C; Forget F; De Geest S; Muermans K; VAN Lierde MA; Macdonald K; Abraham I; De Grève J
    Anticancer Res; 2011 Apr; 31(4):1407-9. PubMed ID: 21508393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate.
    Rutkowski P; Nowecki Z; Nyckowski P; Dziewirski W; Grzesiakowska U; Nasierowska-Guttmejer A; Krawczyk M; Ruka W
    J Surg Oncol; 2006 Mar; 93(4):304-11. PubMed ID: 16496358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of metastatic gastrointestinal stromal tumors with Imatinib: report of four cases].
    Garrido S M; Moneada M M; Tapia N G; Méndez O G; Galindo A H; Huete G A; Ibáñez A L; González S; Alvarez Z M
    Rev Med Chil; 2007 Oct; 135(10):1327-32. PubMed ID: 18180842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nursing implications of imatinib as molecularly targeted therapy for gastrointestinal stromal tumors.
    Griffin JM; Amand MS; Demetri GD
    Clin J Oncol Nurs; 2005 Apr; 9(2):161-9. PubMed ID: 15853160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated surgery improves survival in recurrent gastrointestinal stromal tumors: a retrospective analysis of 144 patients.
    Schurr P; Kohrs D; Reichelt U; Kaifi J; Vashist Y; Bachmann K; Bogoevski D; Yekebas E; Izbicki J
    Dig Surg; 2009; 26(3):229-35. PubMed ID: 19468233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric GI stromal tumors (GISTs): the role of surgery in the era of targeted therapy.
    Heinrich MC; Corless CL
    J Surg Oncol; 2005 Jun; 90(3):195-207; discussion 207. PubMed ID: 15895440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of gastrointestinal stromal tumors--initial experience.
    Lupaşcu C; Andronic D; Moldovanu R; Târcoveanu E; Georgescu S; Ferariu D
    Chirurgia (Bucur); 2010; 105(5):657-62. PubMed ID: 21141090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.